Editorial: Advances in neuromyelitis optica spectrum disorders

Editorial: Advances in neuromyelitis optica spectrum disorders

Bibliographic Details
Main Authors:	Yu Cai, Jodie M. Burton, Fu-Dong Shi, Wei Qiu, Yangtai Guan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Neurology
Subjects:	NMOSD MOGAD molecular mechanism biomarkers therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.1005164/full

Similar Items

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
by: Angelika Bauer, et al.
Published: (2022-11-01)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
by: Alessandro Dinoto, et al.
Published: (2022-03-01)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
by: Yajun Yao, et al.
Published: (2022-08-01)

Cortical Thinning and Ventricle Enlargement in Neuromyelitis Optica Spectrum Disorders
by: De-Cai Tian, et al.
Published: (2020-08-01)

AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature
by: Antonio Luca Spiezia, et al.
Published: (2022-11-01)

Relapsing neuromyelitis optica spectrum disorder
by: M Lakshmi Lavanya, et al.
Published: (2021-01-01)

COVID-19 and the risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study
by: Dongren Sun, et al.
Published: (2023-07-01)

Editorial: Immune-mediated disorders of the spinal cord: Diagnosis, treatment strategies, and outcomes in the 21st century
by: Giulia Fadda, et al.
Published: (2022-11-01)

Effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With Neuromyelitis Optica Spectrum Disorder
by: Ye Liu, et al.
Published: (2021-07-01)

Neuromyelitis optica spectrum disorders: An update
by: Lekha Pandit
Published: (2015-01-01)

Predictive role of blood-based indicators in neuromyelitis optica spectrum disorders
by: Xiqin Fang, et al.
Published: (2023-04-01)

Expression of CD226 is upregulated on Tr1 cells from neuromyelitis optica spectrum disorder patients
by: Ping Chen, et al.
Published: (2022-06-01)

Increased Intracranial Pressure on a Patient with Neuromyelitis Optica Spectrum Disorder
by: Seyed Mohammad Forouzannia, et al.
Published: (2021-07-01)

Helicobacter pylori infection may influence prevalence and disease course in myelin oligodendrocyte glycoprotein antibody associated disorder (MOGAD) similar to MS but not AQP4-IgG associated NMOSD
by: Chaithra Malli, et al.
Published: (2023-05-01)

Diagnostic Potential of Two Novel Biomarkers for Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
by: Ting Xu, et al.
Published: (2023-04-01)

Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56)
by: Maryam Poursadeghfard
Published: (2023-01-01)

Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New?
by: Held F, et al.
Published: (2021-03-01)

Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder
by: Jie Rao, et al.
Published: (2022-04-01)

Editorial: Women in multiple sclerosis and other demyelinating disorders: A global perspective
by: Ethel Ciampi, et al.
Published: (2023-02-01)

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women
by: Lin Han, et al.
Published: (2022-09-01)

Predictive Factors of Resistance to High-Dose Steroids Therapy in Acute Attacks of Neuromyelitis Optica Spectrum Disorder
by: Chuan Qin, et al.
Published: (2020-11-01)

Female sexual dysfunction in newly diagnosed egyptian patients with neuromyelitis optica spectrum disorder
by: Alaa ELmazny, et al.
Published: (2022-03-01)

The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk
by: Hexiang Yin, et al.
Published: (2021-03-01)

Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report
by: Carlo Maiorca, et al.
Published: (2022-01-01)

Serum Albumin Level Can Predict Immunotherapy Response of Neuromyelitis Optica Spectrum Disorders in the Acute Phase
by: Xiang W, et al.
Published: (2024-02-01)

Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations
by: Alberto Vogrig, et al.
Published: (2023-02-01)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
by: Jyh Yung Hor, et al.
Published: (2020-06-01)

Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
by: Iris Kleerekooper, et al.
Published: (2020-12-01)

Epstein–Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders
by: Davide Cossu, et al.
Published: (2023-12-01)

Area postrema syndrome – a challenge for differential diagnosis between multiple sclerosis and neuromyelitis optica spectrum disorders
by: Adriana Octaviana Dulamea, et al.
Published: (2017-12-01)

Plasma exchange as a first line therapy in acute attacks of neuromyelitis optica spectrum disorders
by: B L Kumawat, et al.
Published: (2019-01-01)

Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
by: Edgar Carnero Contentti, et al.
Published: (2021-09-01)

Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica-Spectrum Disorders (NMO-SD): State-of-the-Art and Future Perspectives
by: Giulia Ceglie, et al.
Published: (2020-07-01)

Satralizumab as an add-on treatment in refractory pediatric AQP4-antibody-positive neuromyelitis optica spectrum disorder: a case report
by: Xiaojing Li, et al.
Published: (2023-10-01)

Emerging trends and research foci of neuromyelitis optica spectrum disorder: a 20-year bibliometric analysis
by: Yue Su, et al.
Published: (2023-06-01)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
by: Virginia Rinaldi, et al.
Published: (2022-12-01)

Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis
by: Sanjeev Kharel, et al.
Published: (2021-11-01)

Treating seronegative neuromyelitis optica spectrum disorder with inebilizumab: a case report
by: Dominik Lehrieder, et al.
Published: (2023-11-01)

Relevance of bright spotty lesions in neuromyelitis optica spectrum disorders (NMOSD): a case series
by: Joe Joseph, et al.
Published: (2022-12-01)

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
by: Laura Clarke, et al.
Published: (2021-09-01)